Apogee Therapeutics, Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Large accelerated filer
Business Address 221 CRESCENT ST., WALTHAM, MA, 02453
Mailing Address 221 CRESCENT ST., WALTHAM, MA, 02453
Phone 650-394-5230
Fiscal Year End 1231
EIN 934958665
Financial Overview
FY2025
$-3.30
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 27, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | March 27, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 26, 2026 | View on SEC |
| 8-K Current report of material events | March 25, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 25, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 23, 2026 | View on SEC |
| 8-K Current report of material events | March 23, 2026 | View on SEC |
| 4 Insider stock transaction report | March 13, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
Annual Reports
10-K March 2, 2026
- Successful Initial Public Offering (IPO) in July 2023, which raised substantial capital and listed shares on The Nasdaq Global Market under APGE.
- Lead program APG990 is currently in Phase 2 clinical trials for Atopic Dermatitis and Asthma, with initial data expected in late 2024 and early 2025.
Insider Trading
STRONG SELL 4 insiders
43 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
SANGAMO THERAPEUTICS, INC
SGMO Biological Products, (No Diagnostic Substances)
Zivo Bioscience, Inc.
ZIVO Biological Products, (No Diagnostic Substances)
Quince Therapeutics, Inc.
QNCX Biological Products, (No Diagnostic Substances)
EXOZYMES INC.
EXOZ Biological Products, (No Diagnostic Substances)
Aura Biosciences, Inc.
AURA Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.